04-28-2016, 02:25 AM
Quote:At the hearing, McCaskill and her Republican counterpart, Senator Susan Collins of Maine, honed in on four drugs. Isuprel and Nitropress are heart treatments that Valeant acquired and then quickly raised their prices by 525 percent and 212 percent, respectively. Two others, Syprine and Cuprimine, are used to treat a genetic disorder called Wilson’s disease. Valeant raised Cuprimine’s price for 100 capsules to $26,189 from $888, and Syprine’s increased by more than 30-fold, Collins said. Asked if there was any drug that the company sold in the U.S. that Valeant hadn’t raised the price on after acquiring it through a deal, Pearson said he couldn’t name any.Valeant's `Mistakes' Raised Profit, Destroyed Value, Ackman Says - Bloomberg